{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:36:50Z","timestamp":1788565010689,"version":"build-2803163510"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Allergy"],"abstract":"<jats:p>Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) is a chronic inflammatory disease. Its severe uncontrolled form may share, with asthma and atopic dermatitis, the pathophysiological mechanism of T helper 2 inflammation, characterized by tissue eosinophilia and high local IgE levels. Comorbidities and the severity of symptoms result in a poor quality of life. CRSwNP is difficult to treat both medically and surgically. Systemic corticosteroids are widely used to manage signs and symptoms of this disease. However, prolonged use of systemic corticosteroids is associated with numerous side effects that limit their long-term use. Alternative therapy with new biologic drugs allows good control of the signs and symptoms of CRSwNP, without the side effects of systemic corticosteroids. Through an interview proposed to patients affected by CRSwNP, the use of systemic corticosteroids, their dosage and the methods of administration were analyzed in the period preceding the start of therapy with biological drugs and the real impact of biological therapy on corticosteroid use.<\/jats:p>","DOI":"10.3389\/falgy.2025.1573764","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T06:09:13Z","timestamp":1750054153000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy and limitations of systemic corticosteroids in patients with CRSwNP compared to alternative therapies with monoclonal antibodies: real-life of 101 patients from the Lazio region, Italy"],"prefix":"10.3389","volume":"6","author":[{"given":"F.","family":"Anastasi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Di Nota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Sessi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Marzetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sambito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Della Casa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Pizzolante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Bandiera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"301","DOI":"10.4193\/Rhin20.415","article-title":"Dupilumab reduces systemic corticosteroid use and sinonasal surgery rate in CRSwNP","volume":"59","author":"Desrosiers","year":"2021","journal-title":"Rhinology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"873","DOI":"10.12998\/wjcc.v2.i12.873","article-title":"Rinosinusite cronica eosinofila negli asiatici orientali","volume":"2","author":"Wang","year":"2014","journal-title":"World J Clin Cases: WJCC"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1111\/all.13875","article-title":"EUFOREA consensus on biologics for CRSwNP with or without asthma","volume":"74","author":"Fokkens","year":"2019","journal-title":"Allergy"},{"key":"B4","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1002\/alr.21695","article-title":"International consensus statement on allergy and rhinology: rhinosinusitis","volume":"6","author":"Orlandi","year":"2016","journal-title":"Int Forum Allergy Rhinol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13601-019-0268-5","article-title":"Twelve-year follow-up study after endoscopic sinus surgery in patients with chronic rhinosinusitis with nasal polyposis","volume":"9","author":"Calus","year":"2019","journal-title":"Clin Transl Allergy"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1002\/lary.20653","article-title":"Long-term outcomes from the English national comparative audit of surgery for nasal polyposis and chronic rhinosinusitis","volume":"119","author":"Hopkins","year":"2009","journal-title":"Laryngoscope"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/j.jaci.2018.03.004","article-title":"Endotype-driven care pathways in patients with chronic rhinosinusitis","volume":"141","author":"Bachert","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1111\/all.12644","article-title":"Novel scoring system and algorithm for classifying chronic rhinosinusitis: the JESREC study","volume":"70","author":"Tokunaga","year":"2015","journal-title":"Allergy"},{"key":"B9","doi-asserted-by":"publisher","first-page":"100007","DOI":"10.1016\/j.waojou.2018.12.001","article-title":"Shadow cost of oral corticosteroids-related adverse events: a pharmacoeconomic evaluation applied to real-life data from the severe asthma network in Italy (SANI) registry","volume":"12","author":"Canonica","year":"2019","journal-title":"World Allergy Organization Journal"},{"key":"B10","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.rmed.2009.01.003","article-title":"The cumulative burden of oral corticosteroid side effects and the economic implications of steroid use","volume":"103","author":"Manson","year":"2009","journal-title":"Respir Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4193\/Rhin20.600","article-title":"European position paper on rhinosinusitis and nasal polyps 2020","volume":"58","author":"Fokkens","year":"2020","journal-title":"Rhinology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"CD011993","DOI":"10.1002\/14651858.CD011993.pub2","article-title":"Different types of intranasal steroids for chronic rhinosinusitis","volume":"4","author":"Chong","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"B13","doi-asserted-by":"publisher","first-page":"293","DOI":"10.7326\/0003-4819-154-5-201103010-00003","article-title":"Treatment of chronic rhinosinusitis with nasal polyposis with oral steroids followed by topical steroids: a randomized trial","volume":"154","author":"Vaidyanathan","year":"2011","journal-title":"Ann Intern Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/JAA.S420140","article-title":"Dupilumab reduces asthma disease burden and recurrent SCS use in patients with CRSwNP and coexisting asthma","volume":"17","author":"Gurnell","year":"2024","journal-title":"J Asthma Allergy"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1075066","DOI":"10.3389\/fimmu.2023.1075066","article-title":"Effect of postoperative systemic prednisolone on short-term and long-term outcomes in chronic rhinosinusitis with nasal polyps: a multi-centered randomized clinical trial","volume":"14","author":"Mueller","year":"2023","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1285598","DOI":"10.3389\/fimmu.2024.1285598","article-title":"Exploring the immunopathology of type 2 inflammatory airway diseases","volume":"15","author":"AlBloushi","year":"2024","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"00576","DOI":"10.1183\/23120541.00576-2021","article-title":"Infiammamma di tipo 2 nell\u2019asma E in altre malattie delle vie aeree","volume":"8","author":"Maspero","year":"2022","journal-title":"ERJ Open Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s11882-023-01114-w","article-title":"Type 2 biomarkers for the indication and response to biologics in CRSwNP","volume":"23","author":"Guo","year":"2023","journal-title":"Curr Allergy Asthma Rep"},{"key":"B19","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s12890-022-02046-3","article-title":"Real-life effectiveness of dupilumab in patients with mild to moderate bronchial asthma comorbid with CRSwNP","volume":"22","author":"Minagawa","year":"2022","journal-title":"BMC Pulm Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1007\/s00198-023-06731-9","article-title":"Osteoporotic fractures and corticosteroid use in chronic rhinosinusitis patients: a longitudinal study","volume":"34","author":"Zhou","year":"2023","journal-title":"Osteoporos Int"},{"key":"B21","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.alit.2023.03.007","article-title":"Dupilumab improves eosinophilic otitis media associated with eosinophilic chronic rhinosinusitis","volume":"72","author":"Nakashima","year":"2023","journal-title":"Allergol Int"},{"key":"B22","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s40463-023-00663-4","article-title":"The \"real life\" efficacy of dupilumab is independent of initial polyp size and concomitant steroids in CRSwNP","volume":"52","author":"Campion","year":"2023","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"B23","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.jaci.2022.10.023","article-title":"The efficacy and safety of systemic corticosteroids in chronic rhinosinusitis with nasal polyps: a systematic review and meta-analysis","volume":"151","author":"Liu","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1111\/all.15678","article-title":"Mechanisms of nasal polyp formation in chronic rhinosinusitis with nasal polyps: therapeutic implications","volume":"78","author":"Kato","year":"2023","journal-title":"Allergy"},{"key":"B25","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/alr.22912","article-title":"Short-term corticosteroid treatment in chronic rhinosinusitis with nasal polyps: efficacy and safety","volume":"12","author":"Matsuwaki","year":"2022","journal-title":"Int Forum Allergy Rhinol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1183\/13993003.01902-2020","article-title":"Long-term effects of systemic corticosteroids in CRS with nasal polyps: a retrospective cohort study","volume":"58","author":"Rond\u00f3n","year":"2021","journal-title":"Eur Respir J"},{"key":"B27","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.clim.2023.109876","article-title":"Systemic corticosteroid-induced immunosuppression and risk of infections in chronic rhinosinusitis patients","volume":"156","author":"Singh","year":"2023","journal-title":"Clin Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1519069","DOI":"10.3389\/falgy.2024.1519069","article-title":"Olfactory impairment in Italian patients with chronic rhinosinusitis with nasal polyps: a patient-centered survey","volume":"5","author":"Anastasi","year":"2025","journal-title":"Front Allergy"},{"key":"B29","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/alr.22345","article-title":"The economic burden of chronic rhinosinusitis with nasal polyps in the United States","volume":"9","author":"Gokcan","year":"2019","journal-title":"Int Forum Allergy Rhinol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.jaci.2019.07.032","article-title":"Economic impact of chronic rhinosinusitis and nasal polyps: a systematic review","volume":"145","author":"Suh","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3390\/jpm12060897","article-title":"Survey on use of local and systemic corticosteroids in the management of chronic rhinosinusitis with nasal polyps: identification of unmet clinical needs","volume":"12","author":"De Corso","year":"2022","journal-title":"J Pers Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"951","DOI":"10.3390\/jpm12060951","article-title":"Cost-utility analysis of dupilumab for the treatment of chronic rhinosinusitis with nasal polyps (CRSwNP) in Italy","volume":"12","author":"De Corso","year":"2022","journal-title":"J Pers Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.bjorl.2016.01.010","article-title":"Chronic rhinosinusitis with nasal polyps is associated with chronic otitis media in the elderly","volume":"83","author":"Sun","year":"2017","journal-title":"Braz J Otorhinolaryngol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"CD011991","DOI":"10.1002\/14651858.CD011991.pub2","article-title":"Short-course oral steroids alone for chronic rhinosinusitis","volume":"4","author":"Head","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"B35","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1177\/0194599815572097","article-title":"Clinical practice guideline (update): adult sinusitis","volume":"152","author":"Rosenfeld","year":"2015","journal-title":"Otolaryngol Head Neck Surg"},{"key":"B36","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2147\/JAA.S290424","article-title":"Burden of disease in chronic rhinosinusitis with nasal polyps","volume":"14","author":"Bachert","year":"2021","journal-title":"J Asthma Allergy"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e078430","DOI":"10.1136\/bmjopen-2023-078430","article-title":"Prevalence and influencing factors of sleep disorders in patients with CRS: a protocol for systematic review and meta-analysis","volume":"13","author":"Wu","year":"2023","journal-title":"BMJ Open"},{"key":"B38","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3389\/fnins.2020.00140","article-title":"Mechanisms linking olfactory impairment and risk of mortality","volume":"14","author":"Van Regemorter","year":"2020","journal-title":"Front Neurosci"},{"key":"B39","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1001\/jamaoto.2020.3502","article-title":"Association between olfactory dysfunction and mortality in US adults","volume":"147","author":"Choi","year":"2021","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1016\/j.jaip.2020.06.029","article-title":"The treatment paradigm of chronic rhinosinusitis with nasal polyps in the COVD-19 era","volume":"8","author":"Roland","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1236977","DOI":"10.3389\/falgy.2023.1236977","article-title":"EUFOREA summit in Brussels 2023: inspiring the future of allergy & respiratory care","volume":"4","author":"Hellings","year":"2023","journal-title":"Front Allergy"},{"key":"B42","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.anai.2022.12.022","article-title":"The chronic rhinosinusitis practice parameter","volume":"131","author":"Kim","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1002\/lio2.663","article-title":"The impact of nasal polyps on quality of life in patients with chronic rhinosinusitis","volume":"6","author":"Xie","year":"2021","journal-title":"Laryngosc Investig Otolaryngol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11882-021-00997-x","article-title":"Biological therapies in chronic rhinosinusitis with nasal polyps","volume":"21","author":"Bachert","year":"2021","journal-title":"Curr Allergy Asthma Rep"},{"key":"B45","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1177\/1945892419863167","article-title":"Chronic rhinosinusitis with nasal polyps: quality of life and its predictors","volume":"33","author":"Van Zele","year":"2019","journal-title":"Am J Rhinol Allergy"},{"key":"B46","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/S2213-2600(17)30174-1","article-title":"Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomized, double-blind, placebo-controlled trial","volume":"5","author":"Gevaert","year":"2017","journal-title":"Lancet Respir Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1001\/jama.2019.19356","article-title":"Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: the OSTRO randomized clinical trial","volume":"323","author":"Fokkens","year":"2020","journal-title":"JAMA"},{"key":"B48","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1056\/NEJMoa2023694","article-title":"Efficacy and safety of dupilumab in chronic rhinosinusitis with nasal polyps: results from the SINUS-24 and SINUS-52 trials","volume":"384","author":"Bachert","year":"2021","journal-title":"N Engl J Med"},{"key":"B49","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jaci.2022.05.012","article-title":"Management of chronic rhinosinusitis with nasal polyps: current and future treatment options","volume":"150","author":"Gevaert","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/ACI.0000000000000705","article-title":"Biologics in the treatment of chronic rhinosinusitis with nasal polyps: a systematic review","volume":"21","author":"Zhang","year":"2021","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1183\/13993003.01902-2020","article-title":"Chronic rhinosinusitis with nasal polyps: current concepts and management","volume":"56","author":"Fokkens","year":"2020","journal-title":"Eur Respir J"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10198-023-01573-y","article-title":"Economic burden of chronic rhinosinusitis with nasal polyps and associated comorbidities in Europe: a cost-of-illness analysis","volume":"24","author":"Galli","year":"2023","journal-title":"Eur J Health Econ"},{"key":"B53","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.jaci.2023.05.018","article-title":"Targeting eosinophilic inflammation in chronic rhinosinusitis with nasal polyps: current and emerging therapies","volume":"152","author":"Alangari AA, Alsaleh S, Wali S, Alroqi F, Almuhanna F, Alshamrani M.","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.anai.2022.09.023","article-title":"Dupilumab in chronic rhinosinusitis with nasal polyps: a multicenter real-world evidence study. Annals of allergy","volume":"130","author":"Singh","year":"2023","journal-title":"Asthma Immunol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/S2213-2600(23)00084-7","article-title":"Tralokinumab in severe chronic rhinosinusitis with nasal polyps (TROPOS): a phase 3 randomized controlled trial","volume":"11","author":"Harris","year":"2023","journal-title":"Lancet Respir Med"},{"key":"B56","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1111\/all.15772","article-title":"Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP): a multicentric observational phase IV real-life study (DUPIREAL)","volume":"78","author":"De Corso","year":"2023","journal-title":"Allergy"}],"container-title":["Frontiers in Allergy"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2025.1573764\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T06:09:13Z","timestamp":1750054153000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2025.1573764\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,16]]},"references-count":56,"alternative-id":["10.3389\/falgy.2025.1573764"],"URL":"https:\/\/doi.org\/10.3389\/falgy.2025.1573764","relation":{},"ISSN":["2673-6101"],"issn-type":[{"value":"2673-6101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,16]]},"article-number":"1573764"}}